Search Results - Patricia Pozo‐Rosich

Refine Results
  1. 1
    Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research

    Headache as a Symptom of COVID-19: Narrative Review of 1-Year Research by Edoardo Caronna, Patricia Pozo‐Rosich

    Published 2021
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios

    Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios by Edoardo Caronna, Alicia Alpuente, Marta Torres‐Ferrús, Patricia Pozo‐Rosich

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials

    Non-invasive neuromodulation for migraine and cluster headache: a systematic review of clinical trials by Uwe Reuter, Candace K. McClure, Eric Liebler, Patricia Pozo‐Rosich

    Published 2019
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA

    Influence of headache pain intensity and frequency on migraine-related disability in chronic migraine patients treated with OnabotulinumtoxinA by Marta Torres‐Ferrús, Victor J Gallardo, Alicia Alpuente, Patricia Pozo‐Rosich

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months

    Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months by Edoardo Caronna, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, Patricia Pozo‐Rosich

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Epidemiology, burden and clinical spectrum of cluster headache: a global update

    Epidemiology, burden and clinical spectrum of cluster headache: a global update by Seung Ae Kim, Soyoun Choi, Michelle Sojung Youn, Patricia Pozo‐Rosich, Mi Ji Lee

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Anti-glial nuclear antibody: Marker of lung cancer-related paraneoplastic neurological syndromes

    Anti-glial nuclear antibody: Marker of lung cancer-related paraneoplastic neurological syndromes by Francesc Graus, Angela Vincent, Patricia Pozo‐Rosich, Lídia Sabater, Albert Saiz, Bethan Lang, Josep Dalmau

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks

    Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks by Alicia Alpuente, Victor J Gallardo, Laila Asskour, Edoardo Caronna, Marta Torres‐Ferrús, Patricia Pozo‐Rosich

    Published 2021
    Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review

    Eptinezumab for the preventive treatment of episodic and chronic migraine: a narrative review by Pablo Irimia, Sonia Santos‐Lasaosa, Patricia Pozo‐Rosich, Rogelio Leira, Julio Pascual, J.M. Láinez

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  10. 10
    Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis

    Is erenumab an efficient alternative for the prevention of episodic and chronic migraine in Spain? Results of a cost-effectiveness analysis by Patricia Pozo‐Rosich, José Luís Poveda, Carlos Crespo, María Martínez, José Manuel Rodríguez, Pablo Irimia

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

    Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation by Lars Bendtsen, Simona Sacco, Messoud Ashina, Dimos D. Mitsikostas, Fayyaz Ahmed, Patricia Pozo‐Rosich, Paolo Martelletti

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials

    Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials by Faraidoon Haghdoost, Francesca Puledda, David García-Azorí­n, Eva‐Maria Huessler, Roberta Messina, Patricia Pozo‐Rosich

    Published 2023
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies

    Improvement of migraine depressive symptoms is not related to headache frequency: exploring the impact of anti-CGRP therapies by Marta Torres‐Ferrús, Victor J Gallardo, Alicia Alpuente, Edoardo Caronna, Eulàlia Giné-Ciprés, Patricia Pozo‐Rosich

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis

    The impact of onabotulinumtoxinA on severe headache days: PREEMPT 56-week pooled analysis by Manjit Matharu, Rashmi Halker, Patricia Pozo‐Rosich, Ronald E. DeGryse, Aubrey Manack Adams, Sheena K. Aurora

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study

    Long-term treatment with galcanezumab in patients with chronic migraine: results from the open-label extension of the REGAIN study by Patricia Pozo‐Rosich, Holland C. Detke, Shufang Wang, David Doležil, Lily Q. Li, Sheena K. Aurora, Uwe Reuter

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study

    Impact of anti-CGRP monoclonal antibodies on migraine attack accompanying symptoms: A real-world evidence study by Alicia Alpuente, Anna de la Torre-Suñe, Edoardo Caronna, Eulàlia Giné-Ciprés, Marta Torres‐Ferrús, Patricia Pozo‐Rosich

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas

    Impact of monthly headache days on anxiety, depression and disability in migraine patients: results from the Spanish Atlas by Pablo Irimia, Marco Garrido‐Cumbrera, Sonia Santos‐Lasaosa, M. Aguirre-Vazquez, J. Correa-Fernández, I. Colomina, Patricia Pozo‐Rosich

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    A study of differential microRNA expression profile in migraine: the microMIG exploratory study

    A study of differential microRNA expression profile in migraine: the microMIG exploratory study by Victor J Gallardo, Juan Bernardo Gómez‐Galván, Laila Asskour, Marta Torres‐Ferrús, Alicia Alpuente, Edoardo Caronna, Patricia Pozo‐Rosich

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population

    Early and annual projected savings from anti-CGRP monoclonal antibodies in migraine prevention: a cost-benefit analysis in the working-age population by Carlos Lázaro-Hernández, Edoardo Caronna, Joana Rosell‐Mirmi, Victor J Gallardo, Alicia Alpuente, Marta Torres‐Ferrús, Patricia Pozo‐Rosich

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER study

    Efficacy and safety of eptinezumab for migraine prevention in patients with prior preventive treatment failures: subgroup analysis of the randomized, placebo-controlled DELIVER stu... by Messoud Ashina, Michel Lantéri‐Minet, Anders Ettrup, Cecilie Laurberg Christoffersen, Mette Krog Josiassen, Ravinder Phul, Bjørn Sperling, Patricia Pozo‐Rosich

    Published 2023
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: